Medicenna Therapeutics Corp. (MDNA) Financial Statements

Medicenna Therapeutics Corp. (MDNA) files with the U.S. Securities and Exchange Commission under CIK 0001807983. 10KGenie shows its annual statements from SEC filings.

Key Figures, Fiscal Year 2023

Net Income: -10.05 million CAD
Total Assets: 36.45 million CAD

Fiscal year ended Mar 31, 2023. Latest periodic SEC filing: Jun 27, 2023. Source: SEC filings (EDGAR XBRL). Amounts in CAD.

Open the full financial statements for MDNA in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History